Effect of methyldopa on prolactin serum concentration
Authors:
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 34 (5) , 513-515
Abstract
In a group of ten hypertensive patients, the effects of methyldopa administration in two different formulations on serum prolactin (PRL) were studied. A single oral dose of normal release methyldopa significantly increased serum prolactin levels, peak concentrations occurring 3 to 6 h after drug administration. On the contrary, administration of sustained release methyldopa at the same dose was only followed by slight and not significant fluctuations in prolactin plasma levels. Both formulations produced a significant decrease of systolic and diastolic blood pressures, without significant differences between sustained and normal release methyldopa effects.Keywords
This publication has 15 references indexed in Scilit:
- Amenorrhoea, galactorrhoea, and hyperprolactinaemia induced by methyldopa.BMJ, 1981
- Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.Circulation Research, 1979
- Effects of methyldopa on prolactin and growth hormone.BMJ, 1976
- Letter: side effects of methyldopa.BMJ, 1975
- Letter: Sexual dysfunction due to methyldopa.BMJ, 1974
- Side Effects of Hypotensive Agents Evaluated by a Self-administered QuestionnaireBMJ, 1973
- Galactorrhea and Parkinson-like syndrome: An adverse effect of α-methyldopaMetabolism, 1970
- False Adrenergic TransmittersAnnual Review of Pharmacology, 1968
- Treatment of hypertension with methyldopa.BMJ, 1966
- Lactation Due to MethyldopaBMJ, 1963